Clinical Trial Update: The Confirmatory Olmesartan Plaque Regression Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for olmesartan examining plaque regression in carotid atherosclerosis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Plaque Atherosclerosis
• Essential Hypertension

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Conditions: Essential Hypertension, Carotid Plaque | Phase 4 | Status: TERMINATED